Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Time-dependent association of glucocorticoids with adverse outcome in community-acquired pneumonia: a 6-year prospective cohort study.

Nickler M, Ottiger M, Steuer C, Kutz A, Christ-Crain M, Zimmerli W, Thomann R, Hoess C, Henzen C, Bernasconi L, Huber A, Mueller B, Schuetz P; ProHOSP Study Group.

Crit Care. 2017 Mar 24;21(1):72. doi: 10.1186/s13054-017-1656-7.

2.

The National Early Warning Score (NEWS) for outcome prediction in emergency department patients with community-acquired pneumonia: results from a 6-year prospective cohort study.

Sbiti-Rohr D, Kutz A, Christ-Crain M, Thomann R, Zimmerli W, Hoess C, Henzen C, Mueller B, Schuetz P; ProHOSP Study Group.

BMJ Open. 2016 Sep 28;6(9):e011021. doi: 10.1136/bmjopen-2015-011021.

3.

Pre-analytic factors and initial biomarker levels in community-acquired pneumonia patients.

Kutz A, Grolimund E, Christ-Crain M, Thomann R, Falconnier C, Hoess C, Henzen C, Zimmerli W, Mueller B, Schuetz P; ProHOSP Study Group.

BMC Anesthesiol. 2014 Nov 15;14:102. doi: 10.1186/1471-2253-14-102. eCollection 2014.

4.

Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type.

Grolimund E, Kutz A, Marlowe RJ, Vögeli A, Alan M, Christ-Crain M, Thomann R, Falconnier C, Hoess C, Henzen C, Zimmerli W, Mueller B, Schuetz P; ProHOSP Study Group.

COPD. 2015 Jun;12(3):295-305. doi: 10.3109/15412555.2014.949002. Epub 2014 Sep 17.

PMID:
25230352
5.

Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.

Zhydkov A, Christ-Crain M, Thomann R, Hoess C, Henzen C, Werner Z, Mueller B, Schuetz P; ProHOSP Study Group.

Clin Chem Lab Med. 2015 Mar;53(4):559-66.

PMID:
25014522
6.

Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial.

Schuetz P, Kutz A, Grolimund E, Haubitz S, Demann D, Vögeli A, Hitz F, Christ-Crain M, Thomann R, Falconnier C, Hoess C, Henzen C, Marlowe RJ, Zimmerli W, Mueller B; ProHOSP Study Group.

Int J Cardiol. 2014 Aug 20;175(3):464-72. doi: 10.1016/j.ijcard.2014.06.022. Epub 2014 Jun 27.

PMID:
25005339
7.

Hyponatremia and anti-diuretic hormone in Legionnaires' disease.

Schuetz P, Haubitz S, Christ-Crain M, Albrich WC, Zimmerli W, Mueller B; ProHOSP Study Group.

BMC Infect Dis. 2013 Dec 11;13:585. doi: 10.1186/1471-2334-13-585.

8.

Predictors for length of hospital stay in patients with community-acquired pneumonia: results from a Swiss multicenter study.

Suter-Widmer I, Christ-Crain M, Zimmerli W, Albrich W, Mueller B, Schuetz P; ProHOSP Study Group.

BMC Pulm Med. 2012 May 20;12:21. doi: 10.1186/1471-2466-12-21.

9.

Guidance of antibiotic therapy with procalcitonin in lower respiratory tract infections: insights into the ProHOSP study.

Schuetz P, Christ-Crain M, Albrich W, Zimmerli W, Mueller B; ProHOSP Study Group.

Virulence. 2010 Mar-Apr;1(2):88-92. doi: 10.4161/viru.1.2.10488.

PMID:
21178422
10.

Prognostic value of procalcitonin in community-acquired pneumonia.

Schuetz P, Suter-Widmer I, Chaudri A, Christ-Crain M, Zimmerli W, Mueller B; Procalcitonin-Guided Antibiotic Therapy and Hospitalisation in Patients with Lower Respiratory Tract Infections (ProHOSP) Study Group.

Eur Respir J. 2011 Feb;37(2):384-92. doi: 10.1183/09031936.00035610. Epub 2010 Jul 1.

11.

Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial.

Müller F, Christ-Crain M, Bregenzer T, Krause M, Zimmerli W, Mueller B, Schuetz P; ProHOSP Study Group.

Chest. 2010 Jul;138(1):121-9. doi: 10.1378/chest.09-2920. Epub 2010 Mar 18.

PMID:
20299634
12.

Which patients with lower respiratory tract infections need inpatient treatment? Perceptions of physicians, nurses, patients and relatives.

Baehni C, Meier S, Spreiter P, Schild U, Regez K, Bossart R, Thomann R, Falconnier C, Christ-Crain M, De Geest S, Müller B, Schuetz P; ProHOSP Study Group.

BMC Pulm Med. 2010 Mar 11;10:12. doi: 10.1186/1471-2466-10-12.

13.

Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, Neidert S, Fricker T, Blum C, Schild U, Regez K, Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Mueller B; ProHOSP Study Group.

JAMA. 2009 Sep 9;302(10):1059-66. doi: 10.1001/jama.2009.1297.

PMID:
19738090

Supplemental Content

Loading ...
Support Center